Jolien K. E. Veraart, MD, is affiliated with the University of Groningen, University Medical Center Groningen, Department of Psychiatry, and PsyQ Haaglanden, Parnassia Psychiatric Institute in the Netherlands. Veraart has published research focused on the safety and efficacy of ketamine treatment for depression, particularly in treatment-resistant cases and in patients with a history of psychosis or current psychotic symptoms. The work addresses clinical considerations in major depressive disorder and psychotic disorders. Frequent collaborators include Jeanine Kamphuis, Robert A. Schoevers, and Jan Spijker.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
